Advertisement

Topics

PhotoCure Company Profile

19:15 EST 22nd November 2017 | BioPortfolio

PhotoCure is engaged in the research and development of novel therapeutics and diagnostics and related medical devices based on its proprietary photodynamic therapy (PDT) technologies.

PDT is a two step process involving the application of a drug known as a photosensitiser followed by controlled exposure to a selective light source that activates the drug. In addition, PhotoCure is employing photodynamic technology to develop products for the diagnosis of diseases, a process known as photodynamic diagnosis (PD).



In addition to its lead product, Metvix®, which has received regulatory marketing authorisation approval, PhotoCure has three core PDT/PD platform technologies; Photosensitisers, Photochemical synergism and Photochemical internalisation. PhotoCure has a pipeline of follow-on products and technologies.

Location

Hoffsveien 48
Oslo
0377
Norway

Contact

Phone: +47 22 06 22 10
Fax: +47 22 06 22 18
Email: vh@photocure.no


News Articles [9 Associated News Articles listed on BioPortfolio]

Edison Issues Outlook on Photocure (PHO)

LONDON, UK / ACCESSWIRE / November 13, 2017 / Photocure (OTC PINK: PHCUF, OSE: PHO) is a commercial-stage Norwegian specialty pharmaceutical company that currently markets Hexvix/Cysview for diagno...

Photocure (PHO) - Positive CMS draft rule change

Edison Investment Research - Pharmaceutical & healthcare - Photocure: Photocure announced results for Q217 with 10% growth for the Hexvix/Cysview franchise compared to Q216. The US was a major driver,...

Photocure (PHO) - The stars are aligning for fast growth in the US

Edison Investment Research - Pharmaceutical & healthcare - Photocure: Photocure is a commercial-stage Norwegian specialty pharmaceutical company that currently markets Hexvix/Cysview for diagnosing an...

Photocure ASA: Presentation of the third quarter 2017 results

Photocure will present its third quarter report on Wednesday 8 November 2017 at Hotel Continental, Oslo, Norway. The presentation will begin at 08:30 (CET) and representatives from the company...

Photocure ASA 2017 Q2 - Results - Earnings Call Slides

PhotoCure: Results For Second Quarter And First Half Year Of 2017

  Life Sciences Jobs   ...

Photocure ASA: Results for the third quarter of 2017

Oslo, Norway, 7 November 2017: Photocure ASA (OSE:PHO), today reported a revenue growth of 45% for the important US market in the third quarter of 2017, contributing to Hexvix/Cysview revenues...

Photocure ASA: FDA grants priority review for Cysview® supplemental New Drug Application (sNDA)

Oslo, Norway, October 18, Photocure ASA (OSE: PHO) announced today that the U.S. Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) for Cysview® on...

Drugs and Medications [4 Associated Drugs and Medications listed on BioPortfolio]

Cysview [Photocure Inc.]

These highlights do not include all the information needed to use Cysview safely and effectively. See full prescribing information for Cysview. Cysview (hexaminolevulinate hydrochloride), for Intraves...

Metvixia™ (methyl aminolevulinate) cream, 16.8%for topical use only. not for ophthalmic, oral, or intravaginal usemust be dispensed to and applied by a physician. [Penn Pharmaceutical Services Ltd.]

METVIXIA™ (methyl aminolevulinate) Cream, 16.8%For Topical Use Only. Not for Ophthalmic, Oral, or Intravaginal UseMust be dispensed to and applied by a physician.

Cysview [GE Healthcare Inc.]

These highlights do not include all the information needed to use Cysview safely and effectively. See full prescribing information for Cysview. Cysview (hexaminolevulinate hydrochloride), for Intraves...

Metvixia [Galderma Laboratories, L.P.]

These highlights do not include all the information needed to use METVIXIA safely and effectively.See full prescribing information for METVIXIA. METVIXIA™ (methyl aminolevulinate) Cream, 16.8%For To...

PubMed Articles [0 Results]

None

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Pain Relief During Photodynamic Therapy for Actinic Keratoses With a New Irradiation Protocol

This pilot study will try to minimize the pain during exposure to a new red light source (RhodoLED®, Biofrontera Bioscience GmbH, Leverkusen, Germany) used for PDT without compromising it...

Companies [2 Associated Companies listed on BioPortfolio]

PhotoCure

PhotoCure is engaged in the research and development of novel therapeutics and diagnostics and related medical devices based on its proprietary photodynamic therapy (PDT) technologies. PDT is a two st...

PhotoCure ASA

PhotoCure ASA is a Norwegian company that develops and sells pharmaceuticals and medical devices based on its proprietary photodynamic therapy (PDT) technologies, targeting key dermatology and oncolog...

More Information about "PhotoCure" on BioPortfolio

We have published hundreds of PhotoCure news stories on BioPortfolio along with dozens of PhotoCure Clinical Trials and PubMed Articles about PhotoCure for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of PhotoCure Companies in our database. You can also find out about relevant PhotoCure Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record